Secure Compensation with a Power Morcellators Lawsuit
Seeking compensation for metastatic cancer spread by a surgical device, an increasing number of plaintiffs are filing a power morcellators lawsuit. Our San Diego, CA, law firm is taking cases against the manufacturers of several power morcellators, which have been found to spread cancer cells. Patients, including many women undergoing hysterectomies, have been left with life-threatening and in some cases terminal disease.
Our personal injury lawyers have decades of experience assisting plaintiffs in product liability cases. We have taken on many pharmaceutical giants and recovered substantial compensation for clients. If you or a loved one underwent surgery with a power morcellator and developed metastatic cancer, please contact our office today for a free consultation.
About Power Morcellators
Resembling a power drill, a morcellator is a surgical device used to break up and remove tissue. The technology, approved by the U.S. Food & Drug Administration (FDA) in 1991, is used most often in laparoscopic surgery. It allows surgeons to remove fibroids and uterine tissue through a small incision, providing a minimally invasive procedure with a quicker, easier recovery for patients.
The FDA has estimated 60,000 hysterectomies and myomectomies a year are performed using power morcellators. The electronic blade is also used for gallbladder surgery, removal of the spleen, and some types of liver surgery.
Morcellators and Cancer
The shredding action of power morcellators can spread pieces of tissue throughout the abdominal cavity. This has resulted in abnormal, benign growths on tissue and organs, causing pain and swelling. The growths are cause for concern, but there is a significantly worse problem. Fibroids can harbor undetected, cancerous tissue, and morcellators can spread these microscopic cancer cells, effectively causing metastasis of tumors. This leaves the patient with widespread disease that is much more difficult to treat.
One rare, aggressive form of cancer, uterine sarcoma (leiomyosarcoma), is easily missed in preoperative testing. When a power morcellator is used for uterine surgery, this cancer can become widespread, causing a more dangerous condition. The five-year survival rate for metastatic leiomyosarcoma drops from 50 percent (for non-metastatic forms of the disease) to 4-16 percent.
The FDA had initially approved power morcellator technology without requiring clinical trials. In 2014, the agency issued a strongly worded warning to discourage use of morcellators for laparoscopic surgery... "to reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids.”
In October, 2015, multiple federal lawsuits against Ethicon, Inc., a subsidiary of Johnson & Johnson, were consolidated into multidistrict litigation in Kansas. Ethicon had pulled their morcellator off the market after the FDA’s warning was released – but it was too late for many patients.
When defective medical technology causes devastating harm to the patients it is supposed to benefit, there is a grievous problem.
One wrongful death lawsuit was filed by a Philadelphia man who lost his wife to metastatic leiomyosarcoma less than a year after she had a power morcellator hysterectomy. Cases continue to be filed telling similar stories, with patients battling or having succumbed to cancer that was spread by this device.
When defective medical technology causes devastating harm to the patients it is supposed to benefit, there is a grievous problem. If you or a loved one underwent laparoscopic surgery with a power morcellator and were diagnosed with metastatic cancer, you may be entitled to significant compensation.
Our law firm fights aggressively for victims of defective medical devices and dangerous drugs. We work on a contingency fee basis, so you are not asked to pay legal fees until you have received a settlement or court award. Please contact us today to schedule a free consultation.